PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Molecular discovery paves way for new diabetic heart disease treatments

2015-08-12
(Press-News.org) Researchers at New Zealand's University of Otago have discovered why heart disease is the number-one killer of people with diabetes, a breakthrough finding opening the way for new treatments to combat the disease in diabetic patients by targeting a key protein called Beclin-1.

Diabetes affects more than 365 million people worldwide with rates expected to double by 2030. Recent studies show that at least 60% of people with the disease die because of cardiovascular complications.

Why diabetes takes such a toll on heart health has long remained a mystery. Now, in a new study published in the International Journal of Cardiology, the Otago researchers have identified harmful molecular changes in the cells of diabetic hearts that begin before cardiovascular symptoms even appear.

Using the type-2 diabetic mouse model, the researchers found that a normal cell process called autophagy is deregulated in diabetic hearts. A marked increase in autophagy then triggers activation of pro-cell death proteins, which leads to progressive loss of cardiac cells. As more cells die, cardiac dysfunction develops and heart failure ensues.

Lead researcher Dr Rajesh Katare says the team sought to confirm their laboratory-based results by collaborating with cardiothoracic surgeons at Dunedin Hospital to collect and study heart tissue samples from coronary bypass patients.

The researchers matched around 35 such diabetic patients to comparable non-diabetic ones. Analysis revealed markedly increased autophagy in the diabetic patients' heart tissues compared to the non-diabetic ones.

They also identified that diabetes increases autophagy through activation of the protein (Beclin-1), which Dr Katare says presents "an extremely promising target for new treatments of diabetes-related cardiac disease".

"We found that these molecular alterations begin in the diabetic heart from an early stage of the disease--before any clinically identifiable symptoms--so blocking them could be useful in combating cardiovascular complications in diabetes."

When the researchers lowered the gene expression of Beclin-1 in rat heart cells exposed to high glucose, excessive autophagy and cell death rates were much reduced, he says.

"Given that the growing diabetes epidemic is set to create major global economic and social costs in coming decades, it is very exciting to have opened up a new research avenue that could greatly decrease the disease's burden," Dr Katare says.

INFORMATION:



ELSE PRESS RELEASES FROM THIS DATE:

Powering off TB: New electron transport gene is a potential drug target

Powering off TB: New electron transport gene is a potential drug target
2015-08-12
The U.S. Food and Drug Administration recently approved the first new drug to fight tuberculosis (TB) in more than 40 years, but treatment still takes six months, 200 pills and leaves 40 percent of patients uncured. Thus, new targets are needed. Today in ACS Central Science, researchers report they have identified one such target -- a gene that allows the disease to camp out in human immune cells, and is thus essential for the organism's proliferation. TB kills about 1.3 million people around the world every year. The microorganism that causes the disease, Mycobacterium ...

Retrieving eggs earlier during IVF may improve success rates for older women

2015-08-12
IVF success rates for women aged 43 and above could improve by retrieving eggs from their ovaries at an earlier stage of fertility treatment, according to a new study published today in the Journal of Endocrinology. US-based researchers found that the function of cells which nurse and support the development of eggs declines rapidly after 43, causing the egg to be bombarded by hormones that are normally only released after ovulation. Retrieving eggs from smaller follicles at an earlier stage in the IVF process was found to minimise this risk, resulting in a higher quality ...

Blood vessel 'doorway' lets breast cancer cells spread through blood stream

2015-08-12
August 12, 2015--(BRONX, NY)--Using real-time, high-resolution imaging, scientists have identified how a "doorway" in the blood vessel wall allows cancer cells to spread from breast tumors to other parts of the body. The findings lend support to emerging tests that better predict whether breast cancer will spread, which could spare women from invasive and unnecessary treatments, and could lead to new anti-cancer therapies. The research, conducted by investigators at the NCI-designated Albert Einstein Cancer Center (AECC) and Montefiore Einstein Center for Cancer Care, utilized ...

Postmenopausal women prefer vaginal estrogen to achieve higher sexual quality of life

2015-08-12
CLEVELAND, Ohio (August 12, 2015)--Local vaginal estrogen (VE) appears to have escaped the shroud of doubt cast upon hormone therapy as a result of the Women's Health Initiative Study (WHI) by providing numerous medical benefits without systemic effects. That's according to a new study reported online today in Menopause, the journal of The North American Menopause Society (NAMS). The study demonstrated that postmenopausal women who suffer from painful intercourse and vaginal dryness are more likely to use VE, regardless of whether they use any other type of hormone therapy. ...

Radiation costs vary among Medicare patients with cancer

2015-08-11
Cost of radiation therapy among Medicare patients varied most widely because of factors unrelated to a patient or that person's cancer, report University of California, San Diego School of Medicine researchers in the Journal of Oncology Practice. Year of diagnosis, location of treatment, clinic type and individual radiation provider accounted for 44 to 61 percent of the variation in cost for patients with breast, lung and prostate cancer therapies, according to the study published August 11 online. Factors associated with the patient or patient's tumor accounted for less ...

Deceptive woodpecker uses mimicry to avoid competition

Deceptive woodpecker uses mimicry to avoid competition
2015-08-11
Birds of a feather may flock together, but that doesn't mean they share a genetic background. Though birds were first classified into groups primarily based on appearance, research forthcoming in The Auk: Ornithological Advances by Brett Benz of the American Museum of Natural History, Mark Robbins of the University of Kansas Biodiversity Institute, and Kevin Zimmer of the Los Angeles County Museum of Natural History demonstrates that this method isn't necessarily accurate: in a group of very similar-looking South American woodpecker species, genetic analysis has now shown ...

Penn study details 'rotten egg' gas' role in autoimmune disease

2015-08-11
The immune system not only responds to infections and other potentially problematic abnormalities in the body, it also contains a built-in brake in the form of regulatory T cells, or Tregs. Tregs ensure that inflammatory responses don't get out of hand and do damage. In autoimmune diseases, sometimes these Treg cells don't act as they should. A new study led by Songtao Shi of the University of Pennsylvania has demonstrated how Tregs can themselves be regulated, by an unexpected source: hydrogen sulfide, a gas produced by the body's muscle cells and one often associated ...

Discovery in growing graphene nanoribbons could enable faster, more efficient electronics

2015-08-11
MADISON, Wis. -- Graphene, an atom-thick material with extraordinary properties, is a promising candidate for the next generation of dramatically faster, more energy-efficient electronics. However, scientists have struggled to fabricate the material into ultra-narrow strips, called nanoribbons, that could enable the use of graphene in high-performance semiconductor electronics. Now, University of Wisconsin-Madison engineers have discovered a way to grow graphene nanoribbons with desirable semiconducting properties directly on a conventional germanium semiconductor wafer. ...

New combination treatment effective against melanoma skin

2015-08-11
(SACRAMENTO, Calif.) -- In findings never before seen in melanoma, a novel combination therapy was found to be highly effective at treating patients with skin metastases, new research from UC Davis has shown. Led by Emanual Maverakis of the UC Davis Department of Dermatology, the research found that Interleukin (IL)-2 combined with imiquimod and topical retinoid therapy in patients with so-called "in-transit metastases" is a promising therapeutic option. The findings have been published online first in the Journal of the American Academy of Dermatology (doi:10.1016/j.jaad.2015.06.060). "It's ...

Hepatitis C infection may fuel heart risk

2015-08-11
People infected with the hepatitis C virus are at risk for liver damage, but the results of a new Johns Hopkins study now show the infection may also spell heart trouble. The findings, described online July 27 in The Journal of Infectious Diseases, emerged from a larger ongoing study of men who have sex with men, many but not all of whom were infected with HIV and followed over time to track risk of infection and disease progression. A subset of the participants had both HIV and hepatitis C, two infections that often occur together. Even though people infected with ...

LAST 30 PRESS RELEASES:

New way to find “aged” cells marks fresh approach for research into ageing

From blood sugar to brain relief: GLP-1 therapy slashes migraine frequency

Variability in heart rate during sleep may reveal early signs of stroke, depression or cognitive dysfunction, new study shows

New method to study catalysts could lead to better batteries

Current Molecular Pharmacology impact factor rises to 2.9, achieving Q2 ranking in the Pharmacology & Pharmacy category in 2024 JCR

More time with loved ones for cancer patients spared radiation treatment

New methods speed diagnosis of rare genetic disease

Genetics of cardiomyopathy risk in cancer survivors differ by age of onset

Autism inpatient collection releases genetic, phenotypic data for more than 1,500 children with autism

Targeting fusion protein’s role in childhood leukemia produces striking results

Clear understanding of social connections propels strivers up the social ladder

New research reveals why acute and chronic pain are so different – and what might make pain last

Stable cooling fostered life, rapid warming brought death: scientists use high-resolution fusuline data reveal evolutionary responses to cooling and warming

New research casts doubt on ancient drying of northern Africa’s climate

Study identifies umbilical cord blood biomarkers of early onset sepsis in preterm newborns

AI development: seeking consistency in logical structures

Want better sleep for your tween? Start with their screens

Cancer burden in neighborhoods with greater racial diversity and environmental burden

Alzheimer disease in breast cancer survivors

New method revolutionizes beta-blocker production process

Mechanism behind life-threatening cancer drug side-effect revealed

Weighted vests might help older adults meet weight loss goals, but solution for corresponding bone loss still elusive

Scientists find new way to predict how bowel cancer drugs will stop working – paving the way for smarter treatments

Breast cancer patients’ microbiome may hold key to avoiding damaging heart side-effects of cancer therapies

Exercise-induced protein revives aging muscles and bones

American College of Cardiology issues guidance on weight management drugs

Understanding the effect of bedding on thermal insulation during sleep

Cosmic signal from the very early universe will help astronomers detect the first stars

With AI, researchers find increasing immune evasion in H5N1

Study finds hidden effects of wildfires on water systems

[Press-News.org] Molecular discovery paves way for new diabetic heart disease treatments